arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Neurogene Inc.

NGNE

$35.69 ▲ +0.18 (+0.51%) at close

15 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Neurogene Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $761.1M

Dividend Yield —

Revenue Growth —

Op. Margin None

ROIC -39.0% ↘

FCF / Share $-3.67 ↗

Trailing P/E —

Price / Book 2.1x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-90.35M

↓ -20.2% —

FCF / Share Free cash flow per share

$-3.67

↑ +9.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Financial Health ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
EPS Growth YoY (%)	0.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	5.5% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-71.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-20.2% Weak ↑ Weak Improving Year-over-year change in net income	-106.9% Weak ↓ Weak Declining Year-over-year change in net income	36.9% Excellent ↑ Excellent Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	-82.4% Weak ↓ Weak Declining Year-over-year change in net income	52.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-119.9% Weak ↓ Weak Declining Year-over-year change in net income	37.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-35.6% Weak ↑ Weak Improving Year-over-year change in net income	-69.3% Weak ↓ Weak Declining Year-over-year change in net income	9.0% Fair ↑ Fair Improving Year-over-year change in net income	-175.2% Weak Weak Year-over-year change in net income	-13.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	9.6% Fair Fair Year-over-year change in free cash flow	—	—	8.4% Fair Fair Year-over-year change in free cash flow	-78.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	-130.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-970%)	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	-126.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1153%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	-126.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—
FCF / Net Income (x)	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-39.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-35.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—
Return on Capital (%) (%)	-35.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-46.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-34.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-327%)	-24.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-19.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-61.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-507%)	-42.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-383%)	-17.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-49.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-427%)	-43.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-390%)	-50.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-25.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-20.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-66.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-543%)	13.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	15.1% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Interest Coverage (x)	-20665.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6883.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4631.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-70959.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8156.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-12779.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-103.84M	$-136.59M	$-148.21M	$-37.89M	$-142.47M	$-192.56M	$-143.09M	$-76.93M	$-52.03M	$-32.30M	$-39.53M	$-14.91M	$-11.01M	$-2.00M	$-9.24M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$0.00	$0.05	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-4.24	$-4.28	—	$-20.80	$-22.00	$-12.80	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.67	$-4.07	—	$-16.92	$-18.47	$-10.34	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$17.10	$20.89	$14.51	$44.24	$67.30	$90.63	$74.58	$61.75	$84.26	$123.52	$125.98	$67.60	$-4.35K	—	—
Tangible Book Value per Share (USD)	$17.10	$20.89	$14.51	$44.24	$67.30	$90.63	$74.58	$61.75	$84.26	$123.52	$125.98	$67.60	$-4.35K	—	—
Basic Weighted Avg Shares (shares)	21.33M	17.57M	—	2.76M	2.75M	2.59M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$255.36M	$300.77M	$177.38M	$88.07M	$135.35M	$186.63M	$138.85M	$72.54M	$97.87M	$93.97M	$70.00M	$34.10M	$12.68M	—	—
Total Equity (USD)	$264.89M	$310.38M	$186.02M	$94.33M	$142.86M	$191.22M	$141.69M	$72.67M	$98.89M	$144.66M	$108.42M	$36.15M	$-65.69M	$-51.10M	$-39.31M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$925.00K	$0.00	—	—	—	—	$25.00M	—	—	—	—	—	—	—
Depreciation Expense (USD)	$3.04M	$3.19M	$3.26M	$1.56M	$1.31M	$785.00K	$340.00K	$289.00K	—	—	—	$135.95K	$59.57K	$130.78K	—
Net Income, GAAP (USD)	$-90.35M	$-75.14M	$-36.32M	$-57.56M	$-60.69M	$-33.28M	$-69.44M	$-31.59M	$-50.18M	$-37.00M	$-21.86M	$-24.03M	$-8.73M	$-7.71M	—
Operating Cash Flow (USD)	$-77.17M	$-70.60M	$-51.42M	$-45.61M	$-47.56M	$-24.57M	$-15.39M	$-31.58M	$-44.72M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 62 quarters

Neurogene Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NGNE with peers